About Reid Rubsamen
Form D filings for Flow Pharma from 2018 to 2024 list Reid Rubsamen as chief executive officer and director.
Reid Rubsamen first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Reid Rubsamen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Reid Rubsamen works with at each company, as listed on that company's latest Form D.
Flow Pharma, Inc. · Form D/A, Aug 8, 2024
PS
Pamela Steele
Director
AT
Anthony Tufaro
Director
TB
Tikoes Blankenberg
Director
BO
Babatunde Otulana
Director